Clinical trial
Effect of Proton Pump Inhibitor on Prevention of Tumor Bleeding in Patients Under Palliative Chemotherapy for Unresectable Gastric Cancer: a Randomized, Double Blind, and Placebo Controlled Multicenter Trial
NCT02150447 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Proton Pump Inhibitor on Prevention of Tumor Bleeding in Patients Under Palliative Chemotherapy for Unresectable Gastric Cancer: a Randomized, Double Blind, and Placebo Controlled Multicenter Trial
- Lead sponsor
- National Cancer Center, Korea
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- June 30, 2009
- Completion date
- May 31, 2017
- Enrollment
- 394 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
bleeding, gastric cancer